HEARTWARE, INC.
FRAMINGHAM, MA

HeartWare is dedicated to improving patient care and promoting knowledge and education for healthcare professionals. Meetings and events are frequently updated: please visit this page often for the most current information. Medtronic has a long record of being proactive in establishing policies and practices that support strong corporate governance and transparency in financial reporting. These policies and practices are continually reviewed and enhanced as appropriate. We are fortunate to have a capable, highly engaged and fiercely independent Board of Directors who take corporate governance very seriously. As a result, we were able to anticipate and incorporate many of the leading edge practices well before they were mandated by recent corporate reform measures. While Medtronic has excellent corporate governance systems and financial controls already in place, there is no substitute for strong Board members and effective corporate management who understand their duties to safeguard the Company and the interests of shareholders. Medtronic's management and Directors are determined to live our Mission Statement with passion and integrity, and we will do our best to deliver results that all stakeholders in this great company can take pride in. Andrew “AJ” Jones was doing everything right. “I was in good shape and always in the gym,” he said. “I was making sure my diet was on point.” "I was doing everything right. It was like getting hit by a truck," says AJ. Doctors informed AJ there was only one answer — a new heart. But, he was running out of time. His health had declined so rapidly that he needed a heart pump to help keep him alive long enough while he waited for the right donor. His best option became a left ventricular assist device (LVAD) — a device that helps those with advanced heart failure. The HVAD™ Pump (manufactured by Medtronic) is implanted next to the heart and assists the weakened left ventricle to effectively pump blood throughout the body. The HVAD pump connects to a cable, called a driveline, which exits through the abdomen and connects to the controller, a small computer that operates the pump. The HVAD™ System is powered by two batteries, or one battery and electricity. "I want to help other people in similar positions. That’s where most of my time is being spent now." “Patients used to need ICU support with drug therapy and other acute devices keeping them alive,” says Jim Schuermann, vice president and general manager of Medtronic Mechanical Circulatory Support (MCS). “This therapy provides a bridge on the road to a transplant. Without it, they have no other option.” “Heart failure is a progressive disease,” Schuermann says. “Medtronic now offers an option for those in advanced stages, helping to complete a continuum of care for this patient population.” “I want to help other people in similar positions,” he says. “That’s where most of my time is being spent now.” Slaughter, et al. HeartWare Ventricular Assist System for Bridge to Transplant Combined Results of the Bridge to Transplant and Continued Access Protocol Trial. J Heart Lung Transplant 2013;32:675-683. IMPORTANT SAFETY INFORMATION FOR THE HEARTWARE™ HVAD™ SYSTEM Congestive heart failure is a condition in which a heart cannot pump enough blood to meet the body’s needs. A failing heart works, but not as efficiently as it should. As blood flow leaving the heart slows, blood flow returning to the heart will back up, causing congestion in the tissues. Along with congestion in the tissues, swelling (edema) often results. Doctors use Ventricular Assist Devices (VADs) such as the HeartWare™ HVAD™ System to treat patients who are waiting to receive a heart transplant and have severe heart failure that has not improved despite using all other treatment methods available. The HeartWare HVAD System should not be used in patients who cannot take blood thinning medications. Risks associated with the HeartWare HVAD System include, but are not limited to, surgical complications, stroke, blood clots, bleeding and infection. System for close to a year, Dianne was fortunate enough to receive a heart transplant in 2015 and is doing well.